Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › bimagrumab

bimagrumab

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of bimagrumab

5 trials tracked of bimagrumab: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 37 citations.

5Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 2 4
  1. Phase 3 An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203 Completed · 37 cited
  2. Phase 2 Study of Efficacy and Safety of Bimagrumab in Patients After Hip Fracture Surgery Completed
  3. Phase 2 Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese Completed
  4. Phase 2 A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core Study Completed
  5. Phase 2 Dose Range Finding Study of Bimagrumab in Sarcopenia Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.